Simone Treiger Sredni
AstraZeneca (Netherlands)(NL)AstraZeneca (Singapore)(SG)AstraZeneca (Poland)(PL)AstraZeneca (Finland)(FI)
Publications by Year
Research Areas
Renal and related cancers, Chromatin Remodeling and Cancer, Glioma Diagnosis and Treatment, Cancer Mechanisms and Therapy, MicroRNA in disease regulation
Most-Cited Works
- → Rhabdoid Tumor Predisposition Syndrome(2014)128 cited
- → Identification of MicroRNAs as Potential Prognostic Markers in Ependymoma(2011)117 cited
- → Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets(2010)103 cited
- → Hyperplastic perilobar nephroblastomatosis: Long‐term survival of 52 patients(2005)99 cited
- → Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status(2022)79 cited
- → Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group(2009)66 cited